Science, Products, and Strategies for Dermal Pigmentation Disorders and Skin Whitening
Hyperpigmentation and other skin pigmentations are quite common diseases and disorders. Skin whitening is becoming more popular in many regions of world. It is estimated that global market for skin whitening market will reach $19.8 B by 2018 with CAGR of 13.3%. There are many products and brands for therapeutic and cosmetic uses in the market. In this seminar, we will review the science and technology for the treatment of dermal pigment disorders and for the purpose of whitening skin for cosmetic use, the biological and chemical agents used in many brands and products, as well as the contemporary strategies for removing skin pigments and lightening skin color.
Date: Thursday 12/17/2015 6:30-8:30PM
地点: 2 Davis Drive, RTP, NC 27709 (40 号高速 280 出口附近)
Dr. Wang is a seasoned entrepreneur and expert in the pharmaceutical and cosmetic industries. After obtaining his Ph.D. from Ohio State University in 1994, he spent 13 years in US pharmaceutical companies including Procter & Gamble Pharmaceuticals and Icagen, Inc. and successfully managed several drug discovery programs from their infancy to clinical stages. In 2006, he founded PharmaAdvance, Inc., a China based pharmaceutical CRO company providing R&D serves in the areas of chemistry and pharmacology for pharmaceutical companies worldwide. In 2012, he found Ecstasy LLC in North Carolina; a biotech company specialized in the discovery and the development of pharmaceuticals and cosmeceuticals.
Don (Xiaodong) Wang, Ph.D.
CEO, Ecstasy LLC